Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Neurocrine
Pharma
Neurocrine pays $2.9B for Soleno, its largest M&A deal ever
The acquisition of Soleno and its hyperphagia drug Vykat XR comes a few months after Neurocrine unveiled an obesity pipeline.
Angus Liu
Apr 6, 2026 10:30am
Horizon, Genentech top list of pharma's best places to work
Mar 18, 2021 9:25am
Neurocrine enlists music for mental health awareness campaign
Oct 15, 2020 8:02am
Ingrezza-maker Neurocrine brings TD awareness to the tube
Jan 25, 2019 12:20pm
JPM 2019 wraps on 'cautiously optimistic' note: execs
Jan 10, 2019 12:34pm
Neurocrine's 3rd Ingrezza flop dashes Tourette sales hopes
Dec 13, 2018 11:15am
